CLOSE

Benchmark Investments

Tata India Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
30.98 -0.59(-1.87%) NAV as on 12 May 2026
7.14 % 1 M
7.01 % 1 Y
23.11 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

2.15

As on 31 Mar, 2026
Age :

10 yrs 4 m

Since 28 12 ,2015
Exit Load :

0.25%

AUM :

1,325.19 Crs

Portfolio Price To Book Value :

7.79

Investing Style :

Large Growth

Min. Investment :

SIP 100 & Lumpsum 5000

Category :

sector funds

Fund Manager :

Rajat Srivastava

Launch Date :

28-Dec-15

Scheme Benchmark :

NA

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Apr 30 ,2026
Others 0.42 %
Equity 99.58 %

TOP HOLDINGS

Sun Pharmaceutical Industries...9.87 %
Divi's Laboratories Ltd.5.92 %
Healthcare Global Enterprises...5.45 %
Abbott India Ltd.5.37 %
Max Healthcare Institute Ltd.5.17 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs58.70
Hospital & Healthcare Services32.08
Pesticides & Agrochemicals4.47
Business Support2.94
Chemicals0.72
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)17.1815.8825.0628.6428.10
Net Assets(Rs Crores) (as on 31-Mar-2026) 553.33 493.44 878.70 1183.65 1229.42
Scheme Returns(%)(Absolute)16.04-7.3157.4613.01-0.81
B'mark Returns(%)(Absolute)NANANANANA
Category Rank41/7567/7619/9020/10251/120

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2025-20265.44-0.660.70-6.98
2024-20254.6218.851.96-9.86
2023-202415.1911.1111.3810.75
2022-2023-10.368.14-0.52-4.19
2021-202216.843.710.97-4.64

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.98-0.59(-1.87%)NAV As on 12 May, 202628-Dec-2015Inception Date1,325.19AUM In Cr.7.01%1Y23.11%3Y13.42%5Y11.51%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.01-0.55(-1.32%)NAV As on 12 May, 202613-Jul-2018Inception Date6,668.95AUM In Cr.10.99%1Y27.68%3Y15.77%5Y19.73%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity455.53-6.28(-1.36%)NAV As on 12 May, 202614-Jul-1999Inception Date4,323.29AUM In Cr.10.12%1Y25.89%3Y15.36%5Y15.99%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity41.31-0.69(-1.65%)NAV As on 12 May, 202602-Jul-2018Inception Date2,939.23AUM In Cr.14.85%1Y25.40%3Y14.31%5Y19.76%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity32.73-0.61(-1.83%)NAV As on 12 May, 202610-Jul-2019Inception Date900.87AUM In Cr.12.20%1Y23.87%3Y12.48%5Y18.92%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd